KPF
RNAC icon

K2 Principal Fund’s Cartesian Therapeutics RNAC Stock Holding History

K2 Principal Fund’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33,798
Closed -$1.33M – 268
2022
Q2 		$1.33M Buy
+33,798
New +$1.33M 0.15% 89